Skip to main content

Post COVID CT Requires Global Low Dose Discipline

July 29, 2025
Image: [image credit]

Mark Hait
Mark Hait, Contributing Editor

Chest CT is the linchpin for evaluating lingering respiratory complaints after acute SARS-CoV-2 infection, yet practices vary widely by country, vendor platform and radiologist preference. A new international consensus statement published in Radiology by the Radiological Society of North America aligns 14 nations on when to scan, how to scan and what to call the residual shadows that can persist for months. The document stakes out three goals: prevent unnecessary radiation, avoid mislabeling findings as interstitial lung disease and supply reproducible data for longitudinal research. (RSNA)

Persistent Symptoms, Persistent Demand

The World Health Organization defines post-COVID-19 condition as symptoms that emerge within three months of infection and last at least two months; pooled analyses now place global prevalence near 6 %. (World Health Organization, Nature) Those numbers translate into tens of millions of potential follow-up imaging candidates—many with dyspnea, cough or unexplained desaturation. Radiology departments already strained by cancer screening backlogs face a growing queue of long-COVID referrals, making evidence-based triage essential.

When to Scan and When to Wait

Consensus authors recommend a first chest CT for any patient whose respiratory symptoms persist or worsen three months after infection and endure for at least two additional months in the absence of another diagnosis. Hospitalized patients with moderate-to-severe pneumonia merit a baseline scan three to six months after discharge, given that half show residual lung opacities and one quarter demonstrate restrictive physiology at that interval. Follow-up frequency should be set jointly by pulmonology and radiology, guided by the extent of initial disease and spirometric trends rather than by a fixed timetable. (RSNA Publications)

Dose Discipline under ALARA

Serial imaging risks compounding radiation exposure if protocols mirror standard diagnostic settings. The consensus codifies the “as low as reasonably achievable” (ALARA) principle, capping follow-up studies at 1–3 mSv—one quarter to one half the dose of a typical chest CT. Ultralow protocols below 0.5 mSv are discouraged because ground-glass opacities, a hallmark of viral injury, may be lost in noise. (AuntMinnie) Dose rigor carries financial implications. Under current Medicare fee schedules, technical reimbursement does not differentiate between standard and low-dose thoracic CT, yet the operational savings from reduced tube wear and faster gantry rotation can offset the marginal time required to optimize protocols. Cost avoidance also extends to payers: fewer incidental nodules from lower-dose scans mean fewer downstream PET studies and biopsies.

Naming the Lesions Correctly

Ambiguous terminology can steer patients toward unnecessary antifibrotic therapy or invasive biopsy. The panel endorses the Fleischner Society glossary and introduces the term “post-COVID-19 residual lung abnormality” to replace the catch-all “interstitial lung abnormality,” which occupies a different clinical niche. Standardized descriptors—ground-glass opacity, reticulation, parenchymal band—connect radiologic appearances with underlying pathophysiology and enable registries to track natural history without semantic drift. (RSNA Publications)

Operational Hurdles for Imaging Services

Implementing the guidance demands coordinated changes in scheduling algorithms, protocol libraries and reporting templates. Radiology information systems should flag COVID-19–related studies so technologists automatically select low-dose presets. Natural-language templates that autopopulate Fleischner-compliant descriptors reduce dictation time and reinforce consensus language. Integrating structured CT findings with electronic health-record problem lists gives pulmonologists and primary-care teams a longitudinal view without opening every report.

Reimbursement and Regulatory Signals

The Centers for Medicare & Medicaid Services already ties payment for lung-cancer screening CT to strict dose limits and data submission requirements; a parallel approach for post-COVID imaging could follow if utilization spikes. Commercial payers are experimenting with value-based contracts that penalize high variance in radiation dose across similar indications, creating a financial incentive for health systems to harmonize protocols sooner rather than later. Environmental, Social and Governance scorecards now used by bond-rating agencies include radiation stewardship metrics, linking imaging practice directly to the cost of capital.

Multidisciplinary Management and Future Research

Residual opacities often stabilize or resolve over six to 12 months, but a minority may progress toward fibrosis. The statement therefore urges co-management with pulmonologists who can correlate CT evolution with diffusing capacity, six-minute-walk performance and patient-reported outcomes. Prospective registries planned by RSNA working groups will pool standardized CT and clinical data to identify predictors of irreversible change and therapeutic response.

Artificial-intelligence vendors are already training algorithms to quantify ground-glass volume and vascular pruning on low-dose acquisitions, promising reproducible severity scores that transcend institution or scanner. Prospective trials could then test antifibrotic treatment in patients with algorithm-defined progression rather than relying on subjective radiologist impression.

A New Baseline for Global Practice

The multisociety statement transforms fragmented local habits into a coherent framework that balances diagnostic accuracy, patient safety and resource stewardship. Radiology departments that hard-wire low-dose presets, adopt consensus lexicons and align follow-up intervals with clinical milestones will not only improve care for patients recovering from COVID-19 pneumonia but also establish a template for future post-viral lung surveillance. The pandemic may be receding, yet its imaging legacy demands disciplined, data-driven governance, one scan, one protocol and one shared vocabulary at a time.